Recent

% | $
Quotes you view appear here for quick access.

Trius Therapeutics, AŞ Message Board

  • ships_ashore ships_ashore Apr 24, 2013 9:51 PM Flag

    nasdaq site

    any thoughts on this..saw it on the site

    PRICE/SALES RATIO: [FAIL]

    The prospective company should have a low Price/Sales ratio. Non-cyclical stocks with Price/Sales ratios 3 should never be purchased, however they can be held depending on the investor's risk aversion. TSRX's P/S ratio of 12.41 Based on trailing 12 month sales, is above 3, which is considered very unfavorable by this methodology. Based on this ratio, the stock is quite risky, however if risk does not bother you much, consider holding the stock until the P/S ratio approaches 6.

    Read more: http://www.nasdaq.com/symbol/tsrx/guru-analysis/fisher#ixzz2RR4

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies